尿道結石治療器材市場預測－按產品、最終用戶和地區分類的全球分析－2034年

全球尿道結石治療設備市場預計到 2026 年將達到 19 億美元，並在預測期內以 6.9% 的複合年成長率成長，到 2034 年將達到 33 億美元。

尿道結石是指泌尿系統內形成結石的疾病。尿道結石治療醫療設備是專門用於診斷、治療和管理尿道結石（包括腎結石和尿路結石）的專用儀器和設備。這些器械在微創治療中發揮重要作用，能夠減輕患者的不適感，縮短恢復時間，並改善尿道結石患者的治療效果。

根據歐洲泌尿系統協會（EAU）的數據，尿道結石的盛行率介於1%到20%之間。在加拿大、瑞典和美國等已開發國家，腎結石的盛行率超過10%，因此更為常見。

尿道結石發生率上升

在全球範圍內，腎結石和尿道結石的發生率不斷上升，泌尿尿道結石的盛行率也隨之增加，這是推動尿道結石治療器械市場發展的關鍵因素。生活型態的改變、飲食習慣的改變、飲水不足等因素都加劇了尿道結石道結石的發生率。個案的激增使得有效的管理和治療變得特別重要，這也推動了對尿道結石治療器械的需求。隨著盛行率的持續上升，對體外震波碎石術（ESWL）、輸尿管鏡和取石器械等先進器械的需求也不斷成長，這促使市場尋求創新解決方案。

高昂的醫療費用

治療尿道結石的相關費用，包括手術、醫療設備和後續觀察，可能相當高。這些高昂的費用限制了患者獲得先進治療和器械的機會，尤其是對於經濟困難或保險覆蓋不足的患者。經濟負擔可能會阻礙一些患者選擇先進的治療方法，從而影響這些治療方法的普及，並阻礙市場成長。

對微創手術的需求日益成長

由於微創治療相比傳統手術方法具有許多優勢，例如術後疼痛減輕、住院時間縮短、恢復更快、併發症風險更低，患者越來越傾向於選擇微創治療。這一趨勢導致用於治療尿道結石的醫療設備需求激增，這些器械支援輸尿管鏡、雷射碎石和體外震波碎石等微創技術。此外，這些醫療設備能夠精準定位結石，同時最大限度地減少對周圍組織的傷害。因此，對這些器械的需求不斷成長，推動了市場發展。

感染風險

使用輸尿管支架和體外震波尿道結石系統結石治療器械的侵入性操作會增加感染疾病風險。消毒不當、器械留置時間過長或重複操作都可能導致尿道感染和全身性行為感染。這些感染疾病會引發併發症，延長住院時間，需要額外治療，並對患者的健康產生負面影響，最終抑制市場需求。

新冠疫情的影響

新冠疫情透過擾亂通路和對企業及金融市場的經濟衝擊，擾亂了市場。這些擾亂迫使許多小規模醫院和養老機構暫時關閉。此外，門診預約的延誤導致電話和線上諮詢的需求增加。麻醉和手術名額、病床以及醫護人員的短缺，造成治療嚴重延誤，對全球尿道結石治療器械市場產生了負面影響。

在預測期內，輸尿管腎鏡檢查部分預計將佔最大佔有率。

輸尿管腎鏡預計將佔據最大的市場佔有率。泌尿系統是一種柔軟性或半剛性器械，配備微型攝影機和光纖技術，使泌尿科醫師能夠觀察並觸及輸尿管和腎臟內的結石。這些器械有助於在泌尿道內進行精準操作，從而實現結石碎石、取出或雷射碎石等手術。此外，輸尿管腎鏡在微創治療中發揮著至關重要的作用，透過減輕患者不適、縮短恢復時間以及促進有效結石管理，改變了尿道結石的治療方式。

在預測期內，醫院產業預計將呈現最高的複合年成長率。

預計在預測期內，醫院領域將顯著成長。醫院是尿道結石診斷、治療和管理的關鍵中心。這些機構使用各種尿道結石管理設備，包括切開取石器、輸尿管鏡、取石器、支架和影像設備。醫院提供全面的泌尿系統手術和治療，為尿道結石患者提供住院和門診服務。該領域涵蓋各種類型的醫院，從大規模大學醫院到小規模社區醫院，所有這些醫院都在積極採用和使用尿道結石管理設備，以追求有效的患者照護。

市佔率最大的地區：

在預測期內，亞太地區佔據了最大的市場佔有率，這主要得益於尿道結石盛行率的上升、醫療保健成本的增加、技術的進步以及老年人口的成長。此外，醫療基礎設施的改善、醫療服務可近性的提高以及人們對尿道結石治療方案認知度的提升，也促進了這些設備的普及應用。亞太市場為希望滿足該地區尿道結石患者不斷變化的需求的製造商和供應商提供了極具吸引力的機會。

複合年成長率最高的地區：

在北美，微創手術的普及、積極的研發投入以及有利的健保報銷政策預計將在預測期內推動盈利成長。該地區（包括美國和加拿大）擁有完善的醫療基礎設施、高額的醫療費用支出以及對泌尿系統技術創新的堅定承諾。此外，主要市場參與者的存在，以及對以患者為中心的醫療服務和技術進步的日益重視，已使北美成為尿道結石結石治療領域領先的尖端解決方案中心。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

• 企業概況
  • 對其他市場參與者（最多 3 家公司）進行全面分析
  • 對主要公司進行SWOT分析（最多3家公司）
• 區域細分
  • 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
• 競爭性標竿分析
  • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

第2章：引言

• 概括
• 相關利益者
• 調查範圍
• 調查方法
• 研究材料

第3章 市場趨勢分析

• 促進因素
• 抑制因子
• 機會
• 威脅
• 產品分析
• 最終用戶分析
• 新興市場
• 新冠疫情的感染疾病

第4章：波特五力分析

• 供應商的議價能力
• 買方的議價能力
• 替代品的威脅
• 新進入者的威脅
• 競爭公司之間的競爭

第5章 全球尿道結石治療器材市場：依產品分類

• 體外震波碎石裝置
  • 用於身體
    • 超音波
    • 雷射
    • 氣動
  • 體外
• 輸尿管腎鏡檢查
  • 死板的
  • 靈活的
  • 半剛性

第6章：全球尿道結石治療設備市場：依最終用戶分類

• 診所及門診醫療中心
• 醫院
• 其他最終用戶

第7章 全球尿道結石治療器材市場：依地區分類

• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 義大利
  • 法國
  • 西班牙
  • 其他歐洲國家
• 亞太地區
  • 日本
  • 中國
  • 印度
  • 澳洲
  • 紐西蘭
  • 韓國
  • 其他亞太國家
• 南美洲
  • 阿根廷
  • 巴西
  • 智利
  • 其他南美國家
• 中東和非洲
  • 沙烏地阿拉伯
  • UAE
  • 卡達
  • 南非
  • 其他中東和非洲國家

第8章 主要發展

• 合約、夥伴關係、合作關係、合資企業
• 收購與併購
• 新產品發布
• 業務拓展
• 其他關鍵策略

第9章：公司簡介

• Olympus
• Boston Scientific
• Karl Storz
• Siemens Medical Solutions
• Richard Wolf
• Cook Medical
• Dornier
• Elmed
• MTS Medical
• Direxgroup
• Cybersonics
• Allengers
• BD
• DirexGroup
• CONMED Corporation
• Potent Medical
• HealthTronics, Inc

According to Stratistics MRC, the Global Urolithiasis Management Devices Market is accounted for $1.9 billion in 2026 and is expected to reach $3.3 billion by 2034 growing at a CAGR of 6.9% during the forecast period. Urolithiasis refers to the development of stones in the urinary system. Urolithiasis Management Devices are specialized tools and equipment used in the diagnosis, treatment, and management of urinary stones, including kidney stones and stones within the urinary tract. These devices play a crucial role in minimally invasive treatments, reducing patient discomfort, shortening recovery times, and improving outcomes for individuals suffering from urolithiasis.

According to the European Association of Urology, the prevalence of urinary stones ranges from 1% up to 20%. Renal stones are substantially more common (>10%) in developed nations like Canada, Sweden, and the U.S.

Market Dynamics:

Driver:

Rising prevalence of urolithiasis

The escalating prevalence of urolithiasis, characterised by a rising incidence of kidney stones and urinary tract stones worldwide, serves as a significant driver in the Urolithiasis Management Devices Market. Lifestyle changes, dietary habits, and factors like inadequate hydration contribute to the increased occurrence of urolithiasis. This surge in cases necessitates effective management and treatment, fuelling the demand for urolithiasis management devices. As the prevalence continues to grow, there is a heightened need for advanced devices such as lithotripters, ureteroscopes, and stone retrieval tools, driving the market towards innovative solutions.

Restraint:

High treatment costs

The expenses associated with urolithiasis management, including surgical procedures, medical devices, and follow-up care, can be substantial. These high costs limit accessibility to advanced treatments and devices, particularly for patients with limited financial means or inadequate insurance coverage. The financial burden discourages some individuals from opting for advanced procedures, impacting their adoption and hindering market growth.

Opportunity:

Growing demand for minimally invasive procedures

Patients increasingly prefer minimally invasive treatments due to several advantages, including reduced post-operative pain, shorter hospital stays, quicker recovery times, and a lower risk of complications compared to traditional surgical methods. This trend has surged the demand for urolithiasis management devices that support minimally invasive techniques such as ureteroscopy, laser lithotripsy, and shockwave lithotripsy. Additionally, these devices enable precise targeting of stones while minimising trauma to surrounding tissues. Thus, there is an increasing demand for market growth.

Threat:

Risk of infection

Invasive procedures involving urolithiasis management devices, such as ureteral stents or lithotripsy tools, increase the susceptibility to infections. Improperly sterilised equipment, prolonged device placement, or repeated interventions may lead to urinary tract infections or systemic infections. These infections can cause complications, prolong hospital stays, and necessitate additional treatments, impacting patient health outcomes. As a result, it will hinder market demand.

Covid-19 Impact

The COVID-19 pandemic is causing disruptions in distribution channels and through its financial impact on firms and financial markets. Due to obstacles, various small hospitals and elderly housing units had to be temporarily closed. Additionally, there was a delay in the scheduling of appointments for outpatient clinics, which increased the demand for phone or virtual clinics. The absence of anaesthesia or procedural slots, in-hospital beds, and medical personnel resulted in a major treatment backlog, which had a negative impact on the worldwide urolithiasis management device market.

The ureterorenoscopes segment is expected to be the largest during the forecast period

The ureterorenoscopes segment is estimated to hold the largest share. Ureterorenoscopes consist of flexible or semi-rigid instruments equipped with miniature cameras and fibre-optic technology, allowing urologists to visualise and access stones in the ureter or kidney. They facilitate precise navigation through the urinary tract, enabling procedures like stone fragmentation, retrieval, or laser lithotripsy. Furthermore, ureterorenoscopes play a pivotal role in less invasive interventions, reducing patient discomfort, shortening recovery times, and contributing to effective stone management, thereby shaping the landscape of urolithiasis treatment.

The hospitals segment is expected to have the highest CAGR during the forecast period

The hospitals segment is anticipated to have lucrative growth during the forecast period. Hospitals serve as primary centres for the diagnosis, treatment, and management of urolithiasis cases. Within these facilities, various urolithiasis management devices are utilized, including lithotripters, ureteroscopes, stone retrieval tools, stents, and imaging modalities. Hospitals provide a comprehensive range of urological procedures and surgeries, offering both inpatient and outpatient services for urolithiasis patients. The segment encompasses diverse hospital settings, from large academic medical centres to smaller community hospitals, all contributing to the adoption and utilisation of urolithiasis management devices in the quest for effective patient care.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period due to the rising prevalence of urolithiasis, increasing healthcare expenditure, technological advancements, and a growing geriatric population. Moreover, improving healthcare infrastructure, greater accessibility to medical facilities, and expanding awareness about urolithiasis treatment options fuel the adoption of these devices. The Asia-Pacific market presents lucrative opportunities for manufacturers and providers aiming to cater to the evolving needs of urolithiasis patients in the region.

Region with highest CAGR:

North America is expected to witness profitable growth over the projection period due to preference for minimally invasive procedures, strong research and development activities, and favourable reimbursement policies. The region, encompassing the United States and Canada, boasts a robust healthcare infrastructure, high healthcare expenditures, and a significant focus on technological innovations in urology. Moreover, the presence of key market players, along with a growing emphasis on patient-centric care and technological advancements, positions North America as a leading hub for cutting-edge urolithiasis treatment solutions.

Key players in the market

Some of the key players in the Urolithiasis Management Devices Market include Olympus, Boston Scientific, Karl Storz, Siemens Medical Solutions, Richard Wolf, Cook Medical, Dornier, Elmed, MTS Medical, Direxgroup, Cybersonics, Allengers, BD, DirexGroup, CONMED Corporation, Potent Medical , and HealthTronics, Inc.

Key Developments:

In July 2022, Calyxo announced the successful closure of its Series C investment round, securing USD 32.7 million. Based in California, Calyxo has developed the CVAC Aspiration system, designed to eliminate kidney stones without the need for surgery, utilizing irrigation and aspiration methods.

In March 2022, The FDA recognized Applaud Medical's Acoustic Enhancer technology as a breakthrough product. It is designed to break down calcium-based urinary stones that are obstructing or pose a significant risk of future hindrance, provided they are between 6mm and 20 mm in diameter.

Products Covered:

• Shock Wave Lithotripters
• Ureterorenoscopes

End Users Covered:

• Clinics and Ambulatory Care Centers
• Hospitals
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Urolithiasis Management Devices Market, By Product

• 5.1 Introduction
• 5.2 Shock Wave Lithotripters
  • 5.2.1 Intracorporeal
    • 5.2.1.1 Ultrasound
    • 5.2.1.2 Laser
    • 5.2.1.3 Pneumatic
  • 5.2.2 Extracorporea
• 5.3 Ureterorenoscopes
  • 5.3.1 Rigid
  • 5.3.2 Flexible
  • 5.3.3 Semi Rigid

6 Global Urolithiasis Management Devices Market, By End User

• 6.1 Introduction
• 6.2 Clinics and Ambulatory Care Centers
• 6.3 Hospitals
• 6.4 Other End Users

7 Global Urolithiasis Management Devices Market, By Geography

• 7.1 Introduction
• 7.2 North America
  • 7.2.1 US
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 Italy
  • 7.3.4 France
  • 7.3.5 Spain
  • 7.3.6 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 Japan
  • 7.4.2 China
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 New Zealand
  • 7.4.6 South Korea
  • 7.4.7 Rest of Asia Pacific
• 7.5 South America
  • 7.5.1 Argentina
  • 7.5.2 Brazil
  • 7.5.3 Chile
  • 7.5.4 Rest of South America
• 7.6 Middle East & Africa
  • 7.6.1 Saudi Arabia
  • 7.6.2 UAE
  • 7.6.3 Qatar
  • 7.6.4 South Africa
  • 7.6.5 Rest of Middle East & Africa

8 Key Developments

• 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 8.2 Acquisitions & Mergers
• 8.3 New Product Launch
• 8.4 Expansions
• 8.5 Other Key Strategies

9 Company Profiling

• 9.1 Olympus
• 9.2 Boston Scientific
• 9.3 Karl Storz
• 9.4 Siemens Medical Solutions
• 9.5 Richard Wolf
• 9.6 Cook Medical
• 9.7 Dornier
• 9.8 Elmed
• 9.9 MTS Medical
• 9.10 Direxgroup
• 9.11 Cybersonics
• 9.12 Allengers
• 9.13 BD
• 9.14 DirexGroup
• 9.15 CONMED Corporation
• 9.16 Potent Medical
• 9.17 HealthTronics, Inc

List of Tables

• Table 1 Global Urolithiasis Management Devices Market Outlook, By Region (2023-2034) ($MN)
• Table 2 Global Urolithiasis Management Devices Market Outlook, By Product (2023-2034) ($MN)
• Table 3 Global Urolithiasis Management Devices Market Outlook, By Shock Wave Lithotripters (2023-2034) ($MN)
• Table 4 Global Urolithiasis Management Devices Market Outlook, By Intracorporeal (2023-2034) ($MN)
• Table 5 Global Urolithiasis Management Devices Market Outlook, By Extracorporea (2023-2034) ($MN)
• Table 6 Global Urolithiasis Management Devices Market Outlook, By Ureterorenoscopes (2023-2034) ($MN)
• Table 7 Global Urolithiasis Management Devices Market Outlook, By Rigid (2023-2034) ($MN)
• Table 8 Global Urolithiasis Management Devices Market Outlook, By Flexible (2023-2034) ($MN)
• Table 9 Global Urolithiasis Management Devices Market Outlook, By Semi Rigid (2023-2034) ($MN)
• Table 10 Global Urolithiasis Management Devices Market Outlook, By End User (2023-2034) ($MN)
• Table 11 Global Urolithiasis Management Devices Market Outlook, By Clinics and Ambulatory Care Centers (2023-2034) ($MN)
• Table 12 Global Urolithiasis Management Devices Market Outlook, By Hospitals (2023-2034) ($MN)
• Table 13 Global Urolithiasis Management Devices Market Outlook, By Other End Users (2023-2034) ($MN)
• Table 14 North America Urolithiasis Management Devices Market Outlook, By Country (2023-2034) ($MN)
• Table 15 North America Urolithiasis Management Devices Market Outlook, By Product (2023-2034) ($MN)
• Table 16 North America Urolithiasis Management Devices Market Outlook, By Shock Wave Lithotripters (2023-2034) ($MN)
• Table 17 North America Urolithiasis Management Devices Market Outlook, By Intracorporeal (2023-2034) ($MN)
• Table 18 North America Urolithiasis Management Devices Market Outlook, By Extracorporea (2023-2034) ($MN)
• Table 19 North America Urolithiasis Management Devices Market Outlook, By Ureterorenoscopes (2023-2034) ($MN)
• Table 20 North America Urolithiasis Management Devices Market Outlook, By Rigid (2023-2034) ($MN)
• Table 21 North America Urolithiasis Management Devices Market Outlook, By Flexible (2023-2034) ($MN)
• Table 22 North America Urolithiasis Management Devices Market Outlook, By Semi Rigid (2023-2034) ($MN)
• Table 23 North America Urolithiasis Management Devices Market Outlook, By End User (2023-2034) ($MN)
• Table 24 North America Urolithiasis Management Devices Market Outlook, By Clinics and Ambulatory Care Centers (2023-2034) ($MN)
• Table 25 North America Urolithiasis Management Devices Market Outlook, By Hospitals (2023-2034) ($MN)
• Table 26 North America Urolithiasis Management Devices Market Outlook, By Other End Users (2023-2034) ($MN)
• Table 27 Europe Urolithiasis Management Devices Market Outlook, By Country (2023-2034) ($MN)
• Table 28 Europe Urolithiasis Management Devices Market Outlook, By Product (2023-2034) ($MN)
• Table 29 Europe Urolithiasis Management Devices Market Outlook, By Shock Wave Lithotripters (2023-2034) ($MN)
• Table 30 Europe Urolithiasis Management Devices Market Outlook, By Intracorporeal (2023-2034) ($MN)
• Table 31 Europe Urolithiasis Management Devices Market Outlook, By Extracorporea (2023-2034) ($MN)
• Table 32 Europe Urolithiasis Management Devices Market Outlook, By Ureterorenoscopes (2023-2034) ($MN)
• Table 33 Europe Urolithiasis Management Devices Market Outlook, By Rigid (2023-2034) ($MN)
• Table 34 Europe Urolithiasis Management Devices Market Outlook, By Flexible (2023-2034) ($MN)
• Table 35 Europe Urolithiasis Management Devices Market Outlook, By Semi Rigid (2023-2034) ($MN)
• Table 36 Europe Urolithiasis Management Devices Market Outlook, By End User (2023-2034) ($MN)
• Table 37 Europe Urolithiasis Management Devices Market Outlook, By Clinics and Ambulatory Care Centers (2023-2034) ($MN)
• Table 38 Europe Urolithiasis Management Devices Market Outlook, By Hospitals (2023-2034) ($MN)
• Table 39 Europe Urolithiasis Management Devices Market Outlook, By Other End Users (2023-2034) ($MN)
• Table 40 Asia Pacific Urolithiasis Management Devices Market Outlook, By Country (2023-2034) ($MN)
• Table 41 Asia Pacific Urolithiasis Management Devices Market Outlook, By Product (2023-2034) ($MN)
• Table 42 Asia Pacific Urolithiasis Management Devices Market Outlook, By Shock Wave Lithotripters (2023-2034) ($MN)
• Table 43 Asia Pacific Urolithiasis Management Devices Market Outlook, By Intracorporeal (2023-2034) ($MN)
• Table 44 Asia Pacific Urolithiasis Management Devices Market Outlook, By Extracorporea (2023-2034) ($MN)
• Table 45 Asia Pacific Urolithiasis Management Devices Market Outlook, By Ureterorenoscopes (2023-2034) ($MN)
• Table 46 Asia Pacific Urolithiasis Management Devices Market Outlook, By Rigid (2023-2034) ($MN)
• Table 47 Asia Pacific Urolithiasis Management Devices Market Outlook, By Flexible (2023-2034) ($MN)
• Table 48 Asia Pacific Urolithiasis Management Devices Market Outlook, By Semi Rigid (2023-2034) ($MN)
• Table 49 Asia Pacific Urolithiasis Management Devices Market Outlook, By End User (2023-2034) ($MN)
• Table 50 Asia Pacific Urolithiasis Management Devices Market Outlook, By Clinics and Ambulatory Care Centers (2023-2034) ($MN)
• Table 51 Asia Pacific Urolithiasis Management Devices Market Outlook, By Hospitals (2023-2034) ($MN)
• Table 52 Asia Pacific Urolithiasis Management Devices Market Outlook, By Other End Users (2023-2034) ($MN)
• Table 53 South America Urolithiasis Management Devices Market Outlook, By Country (2023-2034) ($MN)
• Table 54 South America Urolithiasis Management Devices Market Outlook, By Product (2023-2034) ($MN)
• Table 55 South America Urolithiasis Management Devices Market Outlook, By Shock Wave Lithotripters (2023-2034) ($MN)
• Table 56 South America Urolithiasis Management Devices Market Outlook, By Intracorporeal (2023-2034) ($MN)
• Table 57 South America Urolithiasis Management Devices Market Outlook, By Extracorporea (2023-2034) ($MN)
• Table 58 South America Urolithiasis Management Devices Market Outlook, By Ureterorenoscopes (2023-2034) ($MN)
• Table 59 South America Urolithiasis Management Devices Market Outlook, By Rigid (2023-2034) ($MN)
• Table 60 South America Urolithiasis Management Devices Market Outlook, By Flexible (2023-2034) ($MN)
• Table 61 South America Urolithiasis Management Devices Market Outlook, By Semi Rigid (2023-2034) ($MN)
• Table 62 South America Urolithiasis Management Devices Market Outlook, By End User (2023-2034) ($MN)
• Table 63 South America Urolithiasis Management Devices Market Outlook, By Clinics and Ambulatory Care Centers (2023-2034) ($MN)
• Table 64 South America Urolithiasis Management Devices Market Outlook, By Hospitals (2023-2034) ($MN)
• Table 65 South America Urolithiasis Management Devices Market Outlook, By Other End Users (2023-2034) ($MN)
• Table 66 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Country (2023-2034) ($MN)
• Table 67 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Product (2023-2034) ($MN)
• Table 68 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Shock Wave Lithotripters (2023-2034) ($MN)
• Table 69 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Intracorporeal (2023-2034) ($MN)
• Table 70 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Extracorporea (2023-2034) ($MN)
• Table 71 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Ureterorenoscopes (2023-2034) ($MN)
• Table 72 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Rigid (2023-2034) ($MN)
• Table 73 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Flexible (2023-2034) ($MN)
• Table 74 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Semi Rigid (2023-2034) ($MN)
• Table 75 Middle East & Africa Urolithiasis Management Devices Market Outlook, By End User (2023-2034) ($MN)
• Table 76 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Clinics and Ambulatory Care Centers (2023-2034) ($MN)
• Table 77 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Hospitals (2023-2034) ($MN)
• Table 78 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Other End Users (2023-2034) ($MN)